恩德拉生命科学 (ndra.o)

+ 收藏

财务摘要(报告期)(恩德拉生命科学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -1.58-1.53-1.20-0.93-4.56-0.18-0.12-0.07
 每股净资产(元) 0.540.620.931.422.270.160.210.20
 每股经营现金净流量(元) -0.92-0.88-0.64-0.79-4.03-0.15-0.10-0.07
 每股现金流量净额(元) -0.20-0.18-0.01-0.80-1.44-0.020.03-0.05
盈利能力:
 净资产收益率平均(%) -156.42-138.71-77.82-50.29-146.53-94.24-53.48-28.79
 总资产净利率(%) -125.53-101.92-59.40-36.95-119.01-78.43-45.77-24.01
 投入资本回报率ROIC(%) -242.26-198.78-124.85-67.77-338.01-255.56-173.26-79.15
收益质量:
 营业利润/利润总额(%) 104.58105.37107.8999.8899.8499.5499.6599.90
资本结构:
 资产负债率(%) 16.2131.6525.0332.4022.3217.3312.9017.08
 权益乘数 1.191.461.331.481.291.211.151.21
 产权比率 0.190.460.330.480.290.210.150.21
 流动资产/总资产(%) 44.9084.1587.4482.9391.9493.7094.6392.52
 非流动资产/总资产(%) 55.1015.8512.5617.078.066.305.377.48
 流动负债/负债合计(%) 82.4690.1587.8584.9782.3279.7076.0772.69
 非流动负债/负债合计(%) 17.549.8512.1515.0317.6820.3023.9327.31
 归属母公司股东的权益/投入资本(%) 144.35121.74156.61104.64164.30235.84330.76238.06
偿债能力:
 流动比率 3.362.953.983.015.006.789.647.45
 速动比率 3.361.682.621.523.455.248.066.03
 货币资金/流动负债(%) 313.80153.70237.05128.58286.97470.12750.67524.86
 营业利润/流动负债(%) -1,164.96-417.75-291.87-160.46-772.28-577.32-427.78-210.26
 经营活动产生的现金流量净额/流动负债(%) -1,057.34-339.91-234.89-136.85-749.50-567.73-428.24-228.20
 归属母公司股东的权益/负债合计(%) 516.73215.92299.48208.69348.10476.92675.14485.46
 经营活动产生的现金流量净额/负债合计(%) -871.91-306.41-206.35-116.28-616.98-452.49-325.76-165.89
 营业利润/负债合计(%) -960.66-376.58-256.41-136.34-635.74-460.13-325.41-152.85
成长能力:
 总资产同比增长率(%) -27.17-38.40-39.61-39.15-27.97-19.40-11.21-42.13
 每股净资产同比增长率(%) -76.04282.48338.88597.56797.06-48.24-41.06-52.56
 总负债同比增长率(%) -47.0812.4917.1715.41-0.99-0.87-12.3378.48
 基本每股收益同比增长率(%) 65.3556.6651.2230.0817.8410.0014.29-16.67
 归属母公司股东的权益同比增长率(%) -21.45-49.07-48.02-50.39-33.19-22.44-11.04-49.20
 营业利润同比增长率(%) 20.047.947.67-2.94-14.43-16.82-11.27-10.85
 股东权益合计同比增长率(%) -21.45-49.07-48.02-50.39-33.19-22.44-11.04-49.20
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) -2,055,191.00-4,681,814.00-6,458,582.00-4,772,112.00-4,572,436.00-3,776,841.00-2,765,300.00-9,715,390.00
 利润总额TTM(元) -10,060,250.00-11,890,310.00-12,229,701.00-13,263,636.00-13,179,092.00-12,994,124.00-12,212,139.00-11,820,176.00
 投入资本(元) 3,920,239.004,268,381.004,425,317.004,299,637.004,385,049.004,326,392.004,031,376.003,809,329.00
 经营活动产生的现金流量净额TTM(元) -9,548,775.00-10,462,886.00-11,110,961.00-12,177,348.00-12,769,371.00-12,333,408.00-11,833,341.00-11,297,771.00
 归属母公司净利润TTM(元) -10,060,250.00-11,890,310.00-12,229,701.00-13,263,636.00-13,179,092.00-12,994,124.00-12,212,139.00-11,820,176.00

前瞻产业研究院